Safety and Efficacy of a Phase 1b Study of Venetoclax Monotherapy or in Combination With Azacitidine for the Treatment of Relapsed/Refractory MDS
By
Yale Cancer Center
FEATURING
Amer Zeidan
By
Yale Cancer Center
FEATURING
Amer Zeidan
Login to view comments.
Click here to Login